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a  b  s  t  r  a  c  t
Photothermal  therapy  (PTT),  based  on  nanoparticles,  has been  widely  explored  in  the  treatment  of  multi-
ple  diseases.  However,  limited  by laser  penetration  ability,  its treatment  efficiency  can  be  reduced  when
treating  deep  arterial  inflammation,  which  is  the  major  cause  of  atherosclerosis  and  vessels  stenosis.
Magnetic  hyperthermia  (MHT)  has  the  outstanding  tissue  permeability,  while  its magnetothermal  effi-
ciency  was  relatively  poor.  In this  study,  Fe3S4 nanoparticles  (NPs)  were  synthesized  and  characterized,
and  its dual  capacity  to convert  light  and  magnetic  stimulation  into  heat  was confirmed.  The  Fe3S4 NPs




(52.8  mM S ). Besides,  its excellent  effect  in ablating  inflammatory  macrophages  combining  PTT  and
MHT  was  verified  in  vitro.  In vivo experiment  on  Apo  E-/- mice  models  exhibited  that  PTT  combined  with
MHT  could  effectively  eliminate  infiltrating  inflammatory  macrophages  and  further  inhibit  the  formation
of  arterial  stenosis.  This study  concludes  that the  integration  of  PTT  and  MHT  based  on  Fe3S4 NPs  can
serve  as  an  effective  therapeutic  strategy  for  the treatment  of atherosclerosis  and  vessels  stenosis.
© 2019  The  Author(s).  Published  by  Elsevier  Ltd.  This  is an open  access  article  under  the CC  BY  license. Introduction
Atherosclerosis is one of the top health problems affecting
uman worldwide and it is the main cause of many vascular dis-
ases. Large numbers of patients die from vascular diseases every
ear, and this trend is on the rise [1,2]. Recently, it has been
emonstrated that atherosclerosis is essentially an inflammatory
rocess, in which macrophages play important roles, especially in
he course of initiation, growth and eventual rupture of arterial
laques [3–5]. Besides, the major way in clinic to treat atheroscle-
osis is balloon dilatation and stent implantation, which can relieve
schemic symptoms temporarily but also activate macrophages toPlease cite this article in press as: J. Liu, X. Guo, Z. Zhao, et al., Fe3S4
magnetic hyperthermia and photothermal treatment, Appl. Mater. To
ause inflammation at the same time. As a result, various cytokines
ere released by those activated macrophages, leading to the
roliferation of smooth muscle cells (SMCs) and eventually ves-
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sels restenosis [6–8]. Therefore, eliminating local aggregation of
inflammatory macrophages can be an effective approach to inhibit
atherosclerosis and vessels stenosis.
As non-invasive and safe therapeutic agents, nanomaterials
have been widely used in biotherapeutic research for various dis-
eases, especially in cancer therapy [9–15]. Hyperthermia based
on nanomaterials can be divided into two  categories: magnetic
hyperthermia (MHT) and photothermal therapy (PTT). Owing to the
outstanding photothermal conversion efficiency of PTT, nanomate-
rials such as metal compounds [16–20], chalcogenides [21,22] and
pyroelectric materials [23] have shown superiority in destroying
surface tumor cells. However, limited by laser penetration ability,
PTT exhibits disadvantages in the treatment of deep lesions. MHT,
generating from an alternating magnetic field, has the advantage
of tissue penetration, and it can be used without depth limitation
[24–27]. However, the heat yield per nanoparticle by MHT  was
much less than that of PTT. Therefore, combining MHT  and PTT
means producing cumulative heating in targeted sites by exploit-
ing inherent advantages and overcoming respective limitations.nanoparticles for arterial inflammation therapy: Integration of
day (xxxx), https://doi.org/10.1016/j.apmt.2019.100457
Many preliminary researches have confirmed its superiority in
the treatment of deep lesions [28–31]. Our previous studies have
found that photothermal nanomaterials can eliminate inflamma-
tory macrophages around the arterial wall to some extent [32–34],
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ut due to the deep position of arteries, the laser may  be par-
ially absorbed by the surrounding tissues during treatment, thus
educing its therapeutic effect in treating deep artery inflammation.
herefore, taking advantages of PTT and MHT  simultaneously may
chieve better results in the treatment of arterial inflammatory. In
rder to produce enough magnetic hyperthermia in deep position,
 relatively high administered dose is needed, which requires nano-
aterials have the property of good biocompatibility. Since iron is
n important component of hemoglobin and is abundant in human
ody, iron nanoparticles are considered to be more biocompatible
han other metal elements (Cu, Mo). Previous studies have shown
hat iron-based agents, such as FeS and FeS2 nanomaterials, have
ood photothermal conversion efficiency and magnetic properties
35–37].
In this study, Fe3S4 nanoparticles (Fe3S4 NPs) were synthesized,
nd their characterization and photothermal and magnetothermal
roperties were evaluated. The cytotoxicity, PTT and MHT  effect of
e3S4 NPs on macrophages were assessed in vitro. During in vivo
xperiment, Apo E knockout mice were used to construct arterial
nflammation models and PTT combining MHT  therapy based on
he local injection of Fe3S4 NPs were subsequently carried out. The
e3S4 NPs also presented great T2 weighted magnetic resonance
maging properties. Histological analysis was conducted to evaluate
he effect of PTT combined with MHT  in preventing the occurrence
f atherosclerosis and stenosis. The specific mechanism of arte-
ial inflammation therapy using PTT and MHT  was  illustrated in
cheme 1. As far as we know, this is the first research to eliminate
rterial inflammation using combined PTT and MHT  approaches,
hich may  provide a new therapeutic method for the treatment of
therosclerosis and vessels stenosis.
. Experiment section
.1. Materials
Raw264.7, mouse macrophage cell line, was purchased from the
hanghai Cell Bank, the Chinese Academy of Sciences (Shanghai,
hina). Dulbecco’s modified Eagle’s medium (DMEM, with high glu-
ose), fetal bovine serum (FBS, Waltham, MA,  USA), Trypsin-EDTA
0.25%), penicillin/streptomycin were purchased from Gibco (Carls-
ad, CA, USA). Primary antibodies, including F4/80, CD68, CD11b
nd secondary antibodies were purchased from Abcam (Cambridge,
A,  USA). The Cell Counting Kit-8 (CCK-8) and Calcein-AM/PI Dou-
le Stain Kit were obtained from Dojindo (Kumamoto, Japan). Other
hemical reagents were obtained from Shanghai Chemical Reagent
esearch Institute Co. Ltd (Shanghai, China) and used according to
anufacturer’s instructions.
.2. Synthesis and characterization of Fe3S4 NPs
FeSO4·7H2O (1 mmol), L-Cysteine (1 mmol) and poly (vinyl
yrrolidone) (PVP, K30) were mixed together and dissolved in
0 mL  of deionized (DI) water under vigorous magnetic stirring.
hen, 100 L ethylenediamine was added into the above solution.
inally, the resulting solution was transferred to a stainless steel
utoclave, sealed, and heated at 200 ◦C for 24 h. A black precipitate
as collected by centrifugation and washed with ethanol and DI
ater several times.
Transmission electron microscopy (TEM) images were taken
n a transmission electron microscope (TEM-2010F). UV–vis-
IR absorbance spectra were obtained at room temperaturePlease cite this article in press as: J. Liu, X. Guo, Z. Zhao, et al., Fe3S4
magnetic hyperthermia and photothermal treatment, Appl. Mater. To
sing a UV–vis-NIR spectrophotometer (UV-1902PC, Phenix). X-ray
iffraction (XRD) measurement was performed with a D/max-
550 PC X-ray diffractometer (Rigaku). X-ray photoelectron spectra
XPS) analyses were conducted using an ESCA-Lab 250Xi (Thermo PRESS
aterials Today xxx (xxxx) xxx
Scientific) spectrometer. The concentration of iron ions was
measured by an inductively coupled plasma atomic emission spec-
troscopy (ICP-AES; Leeman Laboratories Prodigy). The 915 nm
semiconductor lasers were purchased from Shanghai Xilong Opto-
electronics Technology Co. Ltd., China, whose power could be
adjusted externally (0–2 W).  The output power of lasers was
independently calibrated using a hand-held optical power meter
(Newport model 1918-C, CA, USA).
A thermal imaging camera (GX-300; Shanghai Infratest Elec-
tronics Co., Ltd, China) was  used to monitor temperature change
in real time, every five seconds. To measure the photothermal
performance, the solution (100 L) of Fe3S4 NPs with various
concentrations was irradiated by the 808 nm semiconductor laser
devices at the indicated power density for 5 min. The working
distance was  10 cm and a spot area was ∼ 0.316 cm2. To record
the magnetic hyperthermia effect of the Fe3S4 NPs dispersions,
100 L of aqueous dispersions were conducted on foamed plastic
in inductive coils using an AC magnetic field induction system. The
magneto-optical performance of Fe3S4 NPs (500 g mL−1, 100 L)
was assessed under the simultaneous stimulation including an
808 nm laser irradiation at the safe power (0.3 W cm−2) and a phys-
iologically safe range of AC magnetic field (< 5 × 109 A m−1 s−1) for
5 min.
2.3. Cell culture and characterization
Mouse macrophage cell line Raw264.7, purchased from the
Shanghai Cell Bank, the Chinese Academy of Sciences (Shang-
hai, China), was cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM, with 4500 mg  L−1 glucose), which was  supplemented with
10% fetal bovine serum (FBS, Waltham, MA,  USA) and 1% strepto-
mycin/penicillin (Sigma, St. Louis, MO). The culture condition was
controlled at 37 ◦C in a humidified 5% CO2 atmosphere. In order to
identify Raw 264.7 macrophage properties, flow cytometry and cel-
lular immunofluorescence experiments were performed. For flow
cytometry analysis, specific surface markers of macrophages, CD68
and F4/80 were examined. In immunofluorescence experiments,
surface protein marker CD68 was stained. Then a fluorescence
microscope (Olympus, Japan) and a flow cytometer (Beckman Coul-
ter, Fullerton, CA) were separately used to detect the targeted
markers.
2.4. Cytotoxicity, cell viability assay and intracellular TEM
To evaluate the cytotoxicity of Fe3S4 NPs, Raw264.7 was  seeded
in 96-well plates and co-cultured with different concentrations (0,
100, 300, 500, 800, 1000 g mL−1) of Fe3S4 NPs for 12 h. Cell via-
bility was measured by CCK-8 cell proliferation assay according to
the manufacturer’s instructions. Then the safe concentration was
confirmed and used for the follow-up experiment. To evaluate the
photothermal, magnetic, or the combined effects on Raw264.7, a
suitable concentration of Fe3S4 NPs was  co-cultured with Raw264.7
for 12 h and those cells were subjected to an 808 nm NIR laser irra-
diation, AC magnetic field, combined therapy for 5 min  or not. After
which, the treated cells were stained with calcein AM/PI (Dojindo
Laboratories, Shanghai, China) to observe living cells (Calcein AM,
green fluorescence) and dead cells (PI, red fluorescence) under the
immunofluorescence microscope. Besides, the cell apoptosis assay
was performed using flow cytometry after Annexin V/PI (Dojindonanoparticles for arterial inflammation therapy: Integration of
day (xxxx), https://doi.org/10.1016/j.apmt.2019.100457
Laboratories, Shanghai, China) staining. For the intracellular TEM
assay, those cells at different groups were collected, and subsequent
experiments were performed following the procedures described
previously.
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Scheme 1. The schematic illustration of arterial inflammation therap
.5. Magnetic resonance imaging
A small animal MR  scanner (MesoMR23-060H-I) was used
o scan the Fe3S4 NPs dispersions at different Fe concentra-
ions (0–0.28 mM).  All procedures were performed at room
emperature using a spin echo sequence and the parameters
s TR/TE = 300/20 ms,  repetition time 3. The Fe3S4 NPs (100 L,
00 g mL−1) per mouse were injected around the left carotid
rtery under the guidance of ultrasound and the mice were scanned
ith the same MR  scanner before and after the injection. Dur-
ng the process, the mice were deeply anesthetized to avoid the
nterference caused by unintentional movement of the mice.
.6. Animal preparation for photothermal therapy and magnetic
yperthermia
All animal experiments were processed under the proto-
ols approved by Animal Care and Use Committee of Shanghai
inth People’s Hospital, Shanghai Jiao Tong University, School
f Medicine. 8-week old male Apo E knocked mice were pur-
hased from the Shanghai Research Center for Model Organisms
Shanghai, China) and fed with high-fat diet (21% fat, 0.15%
holesterol) in a specific pathogen-free environment. The ani-
al  models of atherosclerosis were prepared as before. 28 mice
ere anaesthetized with phenobarbital sodium (40 mg  kg−1) by
ntraperitoneal injection. The left carotid arteries were exposed
nd sheathed with a contractile silicon tube, as described previ-
usly. After 14 days, Fe3S4 NPs (500 g mL−1, 100 L), dissolved
n PBS was injected into the left carotid arteries of 21 mice under
ltrasound guidance, while another 7 mice were injected with
n equivalent volume of PBS as the control group. Those mice
njected with Fe3S4 NPs were randomly divided into 3 groups
ccording to different treatments: photothermal therapy group
Fe3S4+PTT), magnetic hyperthermia group (Fe3S4+MHT), and pho-
othermal therapy combined with magnetic hyperthermia group
Fe3S4+PTT + MHT). After 12 h, those three groups were separately
xposed to 808 nm laser at the power density of 0.3 W cm−2, mod-
rate radio frequency of 595 kHz and a current of 14.5 kA magneticPlease cite this article in press as: J. Liu, X. Guo, Z. Zhao, et al., Fe3S4
magnetic hyperthermia and photothermal treatment, Appl. Mater. To
eld strength, or the combination of both for 5 min  separately. GX-
00 photothermal medical device (Shanghai Infratest Electronics
o., Ltd, China) was used to record the temperature of the left
arotid artery dynamically.g magnetic hyperthermia and photothermal therapy simultaneously.
2.7. Histological analysis and blood examination
On the 28th day after operation, mice in all groups were
sacrificed, and the left carotid arteries were obtained. After
which, the vessels were stained by immunofluorescence (CD68
for macrophage, SMA  for SMC, DAPI for nuclei) and the relative
numbers of macrophages around vessels were counted. Besides,
HE stain was used to determine the thickness of the intima and
media of vessels. In order to assess the biocompatibility and toxic-
ity of Fe3S4 NPs in vivo, the major viscera (heart, liver, spleen, lung,
kidney, intestine) were made into sections for haematoxylin/eosin
(HE) staining and their morphological changes were observed. To
measure the distribution of Fe3S4 in vivo, the main organs of mice
in Fe3S4 group and PBS group were dissected on the 1st, 3rd, 7th,
14th day post injection. Iron concentrations in different organs were
then examined using ICP-AES analysis. Besides, the blood samples
of mice in both groups at the timepoints of 3, 7, 14 days after injec-
tion were also collected, and important biochemical parameters
were measured.
2.8. Statistics
Quantitative data was described as means ± standard deviation,
and comparisons among groups were analyzed by one-way analysis
of variance. P-value < 0.05 was defined as statistically significant.
The comparison results were labeled with * for P-value < 0.05, **
for P-value < 0.01 and *** P-value < 0.001.
3. Results and discussion
3.1. Synthesis and characterization of Fe3S4 NPs
Hydrophilic Fe3S4 NPs were prepared by a facile one-pot
hydrothermal synthesis method in the presence of poly-vinyl-
pyrrolidone (PVP). TEM shows good mono-dispersity of the
resulting Fe3S4 NPs (Fig. 1A). Further investigation of microstruc-
ture information of the as-synthesized NPs was  obtained from the
high-resolution transmission electron microscope (HRTEM) image.
The HRTEM image (Fig. 1B) shows a single crystal with an interpla-nanoparticles for arterial inflammation therapy: Integration of
day (xxxx), https://doi.org/10.1016/j.apmt.2019.100457
nar spacing of 0.298 nm,  which corresponds to the d-spacing for
(311) planes of Fe3S4 crystal. According to the TEM images, the
size of Fe3S4 NPs was found to be 1̃3 nm (Fig. 1C). The size is much
smaller than those previously reported nanomaterials using a simi-
ARTICLE IN PRESSG ModelAPMT-100457; No. of Pages 13
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attern  of Fe3S4 NPs.
ar synthetic method. This effective particle size reduction resulted
rom the presence of ethylenediamine, as demonstrated in our pre-
ious work on ultrasmall CuCo2S4 NPs. As illustrated in Fig. 1D, all
f the X-ray diffraction (XRD) peaks of the Fe3S4 NPs could be well
ndexed as greigite Fe3S4 NPs, with lattice parameters matched
ell with those on JCPDS file (card no. 16-0713), indicating the
ormation of the pure phase Fe3S4 with high crystallinity.
The composition and chemical bonding state of the Fe3S4 NPs
ere performed by X-ray photoelectron spectroscopy (XPS, Figure
1 in the Supporting Information), showing that the as-prepared
ample is mainly composed of Fe and S elements without other
bvious impurities (the C and O peaks originate from the ligands).
ig. 2A shows high-resolution XPS analysis of Fe 2p of the NPs. The
wo peaks at 712 eV and 725 eV correspond to Fe3+ ions, and the
ther two peaks at 710.5 eV and 724.0 eV were assigned to Fe2+
pecies, indicating the coexistence of Fe3+and Fe2+ in as-prepared
e3S4 NPs. Also, the ratio of Fe to S in Fe3S4 NPs was determined to
e 0.68, which is less than 3/4. These results confirmed the presence
f large numbers of metal defects, which could contribute to the NIR
bsorption of Fe3S4 NCs. To verify the hypothesis, the optical prop-
rties of Fe3S4 NPs were measured. Fig. 2B shows the UV–vis spectra
f the Fe3S4 NPs. As expected, the aqueous dispersion of Fe3S4
Ps showed strong absorption from visible to NIR region. Besides,
he zeta potential of Fe S NPs (500 g mL−1) was recorded forPlease cite this article in press as: J. Liu, X. Guo, Z. Zhao, et al., Fe3S4
magnetic hyperthermia and photothermal treatment, Appl. Mater. To
3 4
 min  using zeta potential analyser (Nicomp Z3000), and the result
howed that the average zeta potential value was -1.67 mV  (Fig.
2). Greigite Fe3S4 is a counterpart of magnetite (Fe3O4). Although3 4
Fe3S4 nanoparticles can be synthesized by various techniques, the
magnetic thermal performance of these materials has been seldom
investigated. Thus, the magnetically induced heating efficiency of
the aqueous suspensions of Fe3S4 NPs was further studied. 0.1 mL
of aqueous solutions at the varied concentration were placed inside
an AC magnetic field with a moderate radio frequency of 595 kHz
and a current of 14.5 kA. As shown in Fig. 3A, Fe3S4 NPs exhibited
a concentration-dependent magnetic thermal effect. As a control
experiment, the temperature of pure water showed little change.
As seen, the temperature elevation of aqueous suspension at a con-
centration of 500 g mL−1 reached 13 ◦C (Fig. 3A and D), which is
enough to inhibit macrophage proliferation. The photothermal per-
formance of Fe3S4 NPs aqueous suspension (500 g mL−1) under
the irradiation of an 808 nm laser with varied power densities was
further investigated. As shown in Fig. 3B, the Fe3S4 NPs exhibited
an excellent photothermal effect due to the strong NIR absorption.
According to the results from Fig. 3B and E, the power density
was optimized to be 0.3 W cm−2. The photo-magnetic thermal
performance of Fe3S4 NPs (500 g mL−1) under the simultaneous
stimulation including an 808 nm laser irradiation at the safe power
(0.3 W cm−2) and a physiologically safe range of AC magnetic field
was further investigated. It was  found that the temperature ele-
vation could reach by 22.5 ◦C (Fig. 3C and F). Therefore, Fe3S4 NPs
exhibited great potential for photo-magnetic hyperthermia ther-nanoparticles for arterial inflammation therapy: Integration of
day (xxxx), https://doi.org/10.1016/j.apmt.2019.100457
apy of arterial inflammation.
In addition, phantom images of Fe3S4 NPs dispersion with
different Fe concentrations (0-0.30 mM)  were examined using a
ARTICLE IN PRESSG ModelAPMT-100457; No. of Pages 13
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Fig. 2. (A) XPS spectra of Fe 2p, and Fe 3p. (B) UV–vis-NIR absorption spectra of the Fe3S4 NPs at room temperature.

















ith 808 nm NIR laser irradiation under different power density (0, 0.1, 0.3, 0.6 W
ower  density of 0.3 W cm−2 and AC magnetic field (595 kHz, 14.5 kA) simultaneou
mage  of (B). (F) Representative photo-magnetic hyperthermia image of (C).
.5 T MR  scanner. As shown in Fig. 4A, as the Fe concentrations
ncreased, the T2-weight image showed a noticeable darken-
ng effect. Based on the results, we calculated the transverse
elaxivity (r2) value of the Fe3S4 NPs and it was  shown to be
2.8 mM−1 S−1, which exhibited that the Fe3S4 NPs were an effec-
ive MRI  contrast agent (Fig. 4B). Then animal experiments were
arried out to examine the contrast effect of Fe3S4 NPs in vivo.
fter the injection of Fe3S4 NPs around left carotid artery of a
ouse, the image of left neck became darker compared with that
efore injection (Fig. 4C). The results demonstrated that Fe3S4 NPsPlease cite this article in press as: J. Liu, X. Guo, Z. Zhao, et al., Fe3S4
magnetic hyperthermia and photothermal treatment, Appl. Mater. To
ad excellent contrast effect for T2-weighted MRI  both in vivo
nd in vitro and could be an ideal candidate for image-guided
reatment.). (C) Combined effect of Fe3S4 NPs at the concentration of 500 g mL−1 under the
D) Representative magnetothermal image of (A). (E) Representative photothermal
3.2. The cytotoxicity, photothermal and magnetothermal effects
on macrophages in vitro
Raw264.7 used in this work is a mouse macrophage cell line,
which owns the characteristics of rapid growth and strong phago-
cytosis. Therefore, it has been widely applied for the study of
macrophage’s function and characteristics. Raw264.7 was inves-
tigated by flow cytometry and cellular immunofluorescence to
analyze the specific protein markers of macrophage. Cellular
immunofluorescence (Fig. S3A) demonstrated that Raw264.7 wasnanoparticles for arterial inflammation therapy: Integration of
day (xxxx), https://doi.org/10.1016/j.apmt.2019.100457
positive for CD68 (red), with nuclear staining with DAPI (blue).
In addition, flow cytometry analysis showed that Raw264.7 were
strongly positive for F4/80 (94.7% ± 1.37%, Fig. S3B) and CD68
ARTICLE IN PRESSG ModelAPMT-100457; No. of Pages 13













































ig. 4. (A) The T2-weighted MRI  signals intensity of different Fe concentration (0–
ouse  before and after the injection of Fe3S4 NPs around carotid artery.
90.1% ± 2.5%, Fig. S3C), which were both macrophage surface
ntigens. The cytotoxicity of Fe3S4 NPs should be assessed before
ny biomedical applications. After co-culturing with Fe3S4 NPs
or 12 h, the CCK-8 assay was used to detect the concentration-
ependent effect of Fe3S4 NPs on Raw264.7. The results showed
hat no significant difference was observed in cell viability and cell
orphology between the Fe3S4 NPs groups and the control group
t the concentrations under 500 g mL−1. When the concentra-
ion reached 800 g mL−1, the viability of Raw264.7 was slightly
ffected (Fig. 5A). Those results showed that Fe3S4 NPs exhibited
ood biocompatibility at the concentration below 500 g mL−1.
onsidering the magnetothermal curve and photothermal curve
f Fe3S4 NPs described above, 500 g mL-1 was chosen as the con-
entration used in the experiment. Owing to the decrease of laser
enetration, low-laser power (0.3 W cm−2) was used to mimic  the
reatment process in vivo.
To study the thermal effect of Fe3S4 NPs on macrophages,
aw264.7 was co-culturing with Fe3S4 NPs of 500 g mL−1 for
2 h and then exposed to 808 nm laser (0.3 W/cm2), AC magnetic
eld (595 kHz, 14.5 kA) or both for 5 min, separately. Subsequently,
aw264.7 cells were stained with Calcein AM/PI for living cells
green)/dead cells (dead), and then observed under a fluores-
ence microscope. Cell viability was also quantitatively evaluated
sing a CCK-8 assay. Calcein AM/PI results (Fig. 5C) showed that
lmost no dead cells were seen in the control group, PTT + MHT
roup and Fe3S4 group. However, about 50% cells were killed in
e3S4+PTT group and Fe3S4+MHT group, while more than 90% cells
n Fe3S4+PTT + MHT  group were dead. The CCK-8 assay performed
 consistent result with the Calcein AM/PI ((Fig. 5B). Morphologi-
al changes may  occur during the process of apoptosis, including
ell lysis, cell shrinkage, nuclear pyknosis, nuclear fragmentation,
uclear dissolution etc [38–40]. Therefore, TEM was used to identify
he phagocytosis of macrophages towards Fe3S4 NPs and the state
f macrophages. After co-culturing with Fe3S4 NPs of 500 g mL−1
or 12 h, Raw264.7 exhibited good phagocytosis, and no signifi-
ant damage was  found within cells (Fig. 6A a). However, Nuclear
yknosis was observed in Raw264.7 after exposed to AC magnetic
eld for 5 min  and cell shrinkage and nuclear fragmentation were
oticed after irradiated with an 808 nm laser for 5 min  (Fig. 6A b
nd c). Moreover, significant nuclear solubilization and cell lysisPlease cite this article in press as: J. Liu, X. Guo, Z. Zhao, et al., Fe3S4
magnetic hyperthermia and photothermal treatment, Appl. Mater. To
ere observed in those cells after exposure to 808 nm laser irra-
iation and AC magnetic field for 5 min  simultaneously (Fig. 6A d).
low cytometry analysis showed that compared with Fe3S4 groupM)  in vitro. (B) The transverse relaxation rate of Fe3S4 NPs. (C) The MRI  image of a
(7.35 ± 1.45%), Fe3S4+ MHT  group (32.36 ± 8.60%) and Fe3S4+PTT
group (40.53 ± 6.45%), a significantly higher apoptosis index was
found in Fe3S4+PTT + MHT  group (74.56 ± 9.15%). Those results
demonstrated that combining PTT and MHT  of Fe3S4 NPs could
eliminate macrophages effectively and may  have great potentials
to alleviate chronic arterial inflammation.
3.3. Photothermal and magnetothermal effect on carotid artery
inflammation in vivo
The macrophages within vessels are derived from mono-
cytes, which can engulf the excessive lipoprotein to form foam
cells. It has been demonstrated that the accumulation of foam
cells in the subendothelial space is the main pathological pro-
cess of atherosclerosis [41,42]. It is unavoidable that endothelial
cells and SMCs get hurt when treating atherosclerosis by bal-
loon dilatation and/or stent implantation in clinic, which can
stimulate the inflammatory response and lead to the accumula-
tion and activation of macrophages within vessels [43]. Activated
macrophages surrounding vessels release some cytokines and
recruit more inflammation cells, including additional monocytes,
T cells neutrophils, which may  stimulate SMCs hyperplasia and
lead to restenosis of vessels [44,45]. Therefore, the elimination
of inflammatory macrophages might prevent the development of
atherosclerosis and vessels stenosis effectively. As described above,
Apo E (−/−) mice were used to make atherosclerosis models. After
treated with different measures, they were divided into Control
group, Fe3S4+PTT group, Fe3S4+MHT group, and Fe3S4+PTT + MHT
group. The representative white light photos of mice in different
groups were provided in Figure S4 and local temperatures around
left necks were recorded dynamically using an infrared thermal
camera. The average temperature of Fe3S4+PTT group, Fe3S4+MHT
group and Fe3S4+PTT + MHT  group increased to 43.5 ◦C, 37.8 ◦C and
49.8 ◦C, respectively, while that of the control group did not change
dramatically (Fig. 7A–E). After 14 days, the left carotid arteries were
taken out for HE staining and immunofluorescence staining and
the slices were observed under the fluorescence microscope. The
results showed that compared with the control group, the number
of macrophages infiltrated in the Fe3S4+PTT group and Fe3S4+MHTnanoparticles for arterial inflammation therapy: Integration of
day (xxxx), https://doi.org/10.1016/j.apmt.2019.100457
group reduced greatly; while the number of macrophages in the
Fe3S4+PTT + MHT  group was the least, which was significantly less
than other three groups (Fig. 8A and B). This suggests that the
integration of PTT and MHT  can ablate inflammatory macrophages
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he  cell viability of macrophages with or without Fe3S4 NPs (500 g mL−1) after tr
MHT,  595 kHz, 14.5 kA) or DUAL (PTT + MHT, both effects) for 5 min respectively. (
500  g mL−1) after treatment with PTT, MHT  or PTT + MHT  respectively. Scale bar: 
ithin vessels effectively. Moreover, HE staining revealed that the
verage thickness of intima and media in the Fe3S4+PTT group and
e3S4+MHT group was much thinner than that of the control group,
ut the thickness of intima and media of the PTT + MHT group was
he thinnest (Fig. 9A and B). This effect can be explained by the
romotion of SMC  apoptosis and the inhibition of SMC  prolifer-
tion through eliminating inflammatory macrophages. Therefore,
he results suggested that the combination of PTT and MHT  of Fe3S4
Ps can serve as an effective method to inhibit arterial inflamma-
ion and arterial stenosis. However, the optimal concentration of
e3S4 NPs and its corresponding AC magnetic field and laser power
eed to be further studied. Moreover, its long-term effects and
omplications still need in-depth exploration.
.4. Biocompatibility of the Fe3S4 NPsPlease cite this article in press as: J. Liu, X. Guo, Z. Zhao, et al., Fe3S4
magnetic hyperthermia and photothermal treatment, Appl. Mater. To
Good biocompatibility is the prerequisite for the research in the
iving body, the biocompatibility of Fe3S4 NPs in vivo was tested
n addition to the cytotoxicity examination of Fe3S4 NPs in vitro.nt with photothermal therapy (PTT, 808 nm,  0.3 W/cm2), magnetic hyperthermia
resentative images of live (green) and dead (red) cells with or without Fe3S4 NPs
m.  Data are representative of at least three independent experiments.
The blood samples of mice in Fe3S4 group and the control group
were examined at the timepoints of 3 days, 7 days and 14 days.
No significant difference was detected in alanine aminotransferase
(ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN)
and creatinine (CR), which represent the function of liver and kid-
ney (Fig. 10A–D). The serum biochemical examination also showed
that no meaningful changes were found in blood platelet (PLT), D-
Dimer, hemoglobin (HGB), total protein (TP) and albumin (ALB),
indicating that no adverse effects induced by Fe3S4 NPs (Fig. 10E–I).
Additionally, the main organs of Fe3S4 groups and the control group
were excised and then subjected to HE staining. Compared with
the control group, no obvious pathological changes such as inflam-
mation, tissue damage and necrosis were observed in the heart,
intestine, kidney, lung, liver and spleen of the Fe3S4 group mice
(Fig. 10J). Besides, the distribution of Fe3S4 NPs was  also examinednanoparticles for arterial inflammation therapy: Integration of
day (xxxx), https://doi.org/10.1016/j.apmt.2019.100457
by measuring iron concentration. As is shown in Fig. S5, the iron
concentrations in major organs increased significantly at the 1st
day of injection, especially in liver and kidney, and the concentra-
tion nearly recovered to normal level at the 7th day. Those results
Please cite this article in press as: J. Liu, X. Guo, Z. Zhao, et al., Fe3S4 nanoparticles for arterial inflammation therapy: Integration of
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Fig. 6. (A) Representative transmission electron micrographs images of Raw264.7 with Fe3S4 NPs after heat treatment. (a) No significant changes were found in Raw264.7
after  incubation with Fe3S4 NPs (500 g mL−1) for 12 h. (b) Nuclear pyknosis was  observed in Raw264.7 after magnetic hyperthermia (MHT, 595 kHz, 14.5 kA) for 5 min. (c)
Cell  shrinkage and nuclear fragmentation were noticed in Raw264.7 after photothermal therapy (PTT, 808 nm,  0.3 W/cm2) for 5 min. (d) Significant nuclear solubilization and
cell  lysis were detected after exposed to DUAL (PTT + MHT, both effects) for 5 min  simultaneously. White arrows in figures represent the location of the nucleus and black
arrows indicate Fe3S4 NPs engulfed by macrophages. (B) Flow cytometry analysis of Raw264.7 incubated with Fe3S4 NPs (500 g mL−1) and treated with different measures.
Scale  bar: 5 m.
Fig. 7. In vivo heat therapy of Fe3S4 NPs on mice model. (A) Infrared thermal image of a mouse injected with PBS and treated with DUAL (PTT + MHT, both effects). (B)
Infrared thermal image of a mouse injected with Fe3S4 NPs and treated with magnetic hyperthermia (MHT, 595 kHz, 14.5 kA). (C) Infrared thermal image of a mouse injected
with  Fe3S4 NPs and treated with photothermal therapy (PTT, 808 nm,  0.3 W/cm2). (D) Infrared thermal image of a mouse injected with Fe3S4 NPs and treated with DUAL
(PTT  + MHT, both effects). (E) Representative temperature changes around left neck of mice at the group of control, Fe3S4+MHT, Fe3S4+PTT, Fe3S4+PTT + MHT respectively.
Data  are representative of at least three independent experiments.
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Fig. 8. (A) Representative immunofluorescence images of carotid artery inflammation in mice model. a, b, c and d are representative images of SMA  (green) and CD68 (red)
co-staining in collar-implanted group mice (Control), collar-implanted group mice with Fe3S4 NPs (500 g ml−1, 100 L) injection and photothermal therapy (PTT, 808 nm,
0.3  W/cm2) for 5 min  (Fe3S4+PTT), collar-implanted group mice with Fe3S4 NPs (500 g ml−1, 100 L) injection and magnetic hyperthermia (MHT, 595 kHz, 14.5 kA) for 5 min
(Fe3S4+MHT), collar-implanted group mice with Fe3S4 NPs (500 g ml−1, 100 L) injection and DUAL (PTT + MHT, both effects) for 5 min  (Fe3S4 +PTT + MHT) respectively. e,
f,  g and h are high magnification images of a, b, c and d respectively. (B) Statistics result of the number of macrophages in different groups. Data are representative of at least
three  independent experiments. Scale bar: 100 m.
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Fig. 9. (A) Representative HE images of carotid artery thickness in mice model. a, b, c and d are the intima and media thickness images of collar-implanted group mice
(Control), collar-implanted group mice with Fe3S4 NPs (500 g ml−1, 100 L) injection and photothermal therapy (PTT, 808 nm at 0.3 W/cm2) for 5 min  (Fe3S4+PTT), collar-
implanted group mice with Fe3S4 NPs (500 g ml−1, 100 L) injection and magnetic hyperthermia (MHT, 595 kHz, 14.5 kA) for 5 min  (Fe3S4+MHT), collar-implanted group
mice  with Fe3S4 NPs (500 g ml−1, 100 L) injection and DUAL (PTT + MHT, both effects) for 5 min  (Fe3S4 +PTT + MHT) respectively. e, f, g and h are high magnification images
of  a, b, c and d respectively. (B)Statistics result of artery thickness in different groups. Data are representative of at least three independent experiments. Scale bar: 100 m.
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Fig. 10. Biocompatibility assay of Fe3S4 NPs in vivo. Blood biochemical results of control group and Fe3S4 group at different time points (3 days, 7 days, 14 days) after injection,
i , (C) b
( s of ma










ncluding (A) alanine aminotransferase (ALT), (B) aspartate aminotransferase (AST)
G)  hemoglobin (HGB), (H) total protein (TP), (I) albumin (ALB). (J) HE staining result
ung,  liver, spleen between control group and Fe3S4 groups. Data are representative
ndicated that Fe3S4 NPs could be cleared from body in short time,
hus reducing its side effect on major organs in vivo. Those results
llustrate that Fe3S4 NPs has no obvious toxic effects and can be
afely applied to the living body.
. Conclusions
In conclusion, Fe3S4 NPs were successfully synthesized withPlease cite this article in press as: J. Liu, X. Guo, Z. Zhao, et al., Fe3S4
magnetic hyperthermia and photothermal treatment, Appl. Mater. To
igh photothermal efficiency and good magnetothermal efficiency.
n vitro results showed that Fe3S4 NPs had superior biocompatibility
nd great T2 weighted MRI  properties and could ablate inflamma-
ory macrophages efficiently with reduced laser power exposurelood urea nitrogen (BUN), (D) creatinine (CR), (E) blood platelet (PLT), (F) D-Dimer,
in visceral organs. No significant changes were observed in heart, intestine, kidney,
least three independent experiments. Scale bar: 100 m.
and reduced magnetic field frequency. In vivo experiments on Apo
E knockout mice suggested that the combination of photothermal
therapy and magnetic hyperthermia was effective in eliminating
inflammatory macrophages and further inhibiting the formation
of atherosclerosis and arterial stenosis. Nevertheless, the optimal
therapeutic concentration of Fe3S4 NPs and the corresponding AC
magnetic strength and laser power were to be further investigated.
In conclusion, this work demonstrates that the integration of pho-nanoparticles for arterial inflammation therapy: Integration of
day (xxxx), https://doi.org/10.1016/j.apmt.2019.100457
tothermal therapy and magnetic hyperthermia based on Fe3S4 NPs
can alleviate inflammatory macrophages effectively, which may
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